Showing results (101-110 of 171) with videos related to
Sort By:
Pageof 18
JAMA Network Open|July 12, 2021
Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric CancerGeoffrey Y Ku, Yelena Kemel, Steve B Maron, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancerDavid H Ilson, Manjit Bains, David P Kelsen, et al.Journal of Gastrointestinal Oncology|April 30, 2019
Maximizing response: a case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinomaMegan Greally, Rajiv Agarwal, Imane El Dika, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinomaNabil P Rizk, Ennapadam Venkatraman, Manjit S Bains, et al.The Lancet. Oncology|May 22, 2020
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trialYelena Y Janjigian, Steven B Maron, Walid K Chatila, et al.Annals of Surgical Oncology|January 7, 2016
Patterns and Predictors of Weight Loss After Gastrectomy for CancerJeremy L Davis, Luke V Selby, Joanne F Chou, et al.Journal of Cancer Research and Clinical Oncology|May 13, 2022
Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancerNicole M Myer, Kohei Shitara, Hyun C Chung, et al.Journal of Thoracic Disease|June 11, 2019
Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastasesYongshun Chen, Xinyu Cheng, Haixia Song, et al.Journal for Immunotherapy of Cancer|May 16, 2014
Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanomaJianda Yuan, Geoffrey Y Ku, Matthew Adamow, et al.JCO Precision Oncology|April 22, 2026
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal AdenocarcinomaSamuel L Cytryn, Raktim Borpatragohain, Karmelina Charalambous, et al.Pageof 18